🇺🇸 FDA
Pipeline program

Bimatoprost SR

1698-302-007

Phase 3 small_molecule active

Quick answer

Bimatoprost SR for Open-angle Glaucoma, Ocular Hypertension is a Phase 3 program (small_molecule) at AbbVie Deutschland GmbH & Co. KG with 1 ClinicalTrials.gov record(s).

Program details

Company
AbbVie Deutschland GmbH & Co. KG
Indication
Open-angle Glaucoma, Ocular Hypertension
Phase
Phase 3
Modality
small_molecule
Status
active

Clinical trials